Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-17 4:05 pm Purchase | 13D | AVENUE THERAPEUTICS INC PA ATXI | Fortress Biotech Inc. FBIO | 3,564,059 8% | 2,515,003 (+239.74%) | View |
| 2024-01-02 3:45 pm Purchase | 13G | AVENUE THERAPEUTICS INC NE ATXI | SABBY MANAGEMENT LLC | 661,056 11% | 397,056 (+150.40%) | View |
| 2023-12-13 4:03 pm Sale | 13G | AVENUE THERAPEUTICS INC PA ATXI | Davidow Robert L | 1,309,800 9.89% | -617,000 (-32.02%) | View |
| 2023-11-28 4:05 pm Purchase | 13G | AVENUE THERAPEUTICS INC PA ATXI | Davidow Robert L | 1,926,800 14.5% | 1,926,800 (New Position) | View |
| 2023-09-18 5:08 pm Purchase | 13D | AVENUE THERAPEUTICS INC PA ATXI | Fortress Biotech Inc. FBIO | 1,049,056 12.1% | 1,049,056 (New Position) | View |
| 2023-02-14 11:22 am Sale | 13G | AVENUE THERAPEUTICS INC PA ATXI | CVI Investments Inc. | 251,011 4.9% | -21,689 (-7.95%) | View |
| 2023-01-06 4:31 pm Sale | 13D | AVENUE THERAPEUTICS INC NE ATXI | Fortress Biotech Inc. FBIO | 578,227 11.3% | -3,261,869 (-84.94%) | View |
| 2023-01-04 08:25 am Purchase | 13G | AVENUE THERAPEUTICS INC NE ATXI | SABBY MANAGEMENT LLC | 264,000 11% | 264,000 (New Position) | View |
| 2022-12-14 4:06 pm Sale | 13G | AVENUE THERAPEUTICS INC NE ATXI | Nantahala Capital Management LLC | 0 0% | -1,453,166 (Position Closed) | View |
| 2022-10-19 07:26 am Sale | 13D | AVENUE THERAPEUTICS INC NE ATXI | InvaGen Pharmaceuticals Inc. | 0 0% | -10,660,228 (Position Closed) | View |
| 2022-10-17 12:01 pm Purchase | 13G | AVENUE THERAPEUTICS INC PA ATXI | CVI Investments Inc. | 272,700 6.6% | 272,700 (New Position) | View |
| 2022-10-17 06:01 am Purchase | 13G | AVENUE THERAPEUTICS INC NE ATXI | INTRACOASTAL CAPITAL LLC | 216,790 4.99% | 216,790 (New Position) | View |
| 2022-07-28 4:30 pm Purchase | 13D | AVENUE THERAPEUTICS INC NE ATXI | InvaGen Pharmaceuticals Inc. | 10,660,228 46.95% | 599,716 (+5.96%) | View |
| 2022-02-14 08:31 am Purchase | 13G | AVENUE THERAPEUTICS INC NE ATXI | Nantahala Capital Management LLC | 1,453,166 7.7% | 1,453,166 (New Position) | View |
| 2022-02-09 3:24 pm Sale | 13G | AVENUE THERAPEUTICS INC NE ATXI | VANGUARD GROUP INC | 452,653 2.42% | -487,053 (-51.83%) | View |
| 2022-02-09 3:24 pm Sale | 13G | AVENUE THERAPEUTICS INC NE ATXI | VANGUARD INDEX FUNDS | 452,653 2.42% | -386,174 (-46.04%) | View |
| 2021-02-12 5:20 pm Sale | 13G | AVENUE THERAPEUTICS INC NE ATXI | Opaleye Management Inc. | 0 0% | -1,035,000 (Position Closed) | View |
| 2021-02-10 10:39 am Purchase | 13G | AVENUE THERAPEUTICS INC NE ATXI | VANGUARD GROUP INC | 939,706 5.61% | 939,706 (New Position) | View |
| 2021-02-08 10:37 am Purchase | 13G | AVENUE THERAPEUTICS INC NE ATXI | VANGUARD INDEX FUNDS | 838,827 5.01% | 838,827 (New Position) | View |
| 2020-02-14 4:30 pm Purchase | 13G | AVENUE THERAPEUTICS INC NE ATXI | Opaleye Management Inc. | 1,035,000 6.21% | 485,000 (+88.18%) | View |